12:00 AM
 | 
Mar 27, 2000
 |  BC Week In Review  |  Company News  |  Deals

MediGene, Schering deal

MediGene was to announce today that it has granted Schering a worldwide exclusive development and commercialization license to its Viral Vaccine to treat precancerous lesions...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >